TABLE 3.
Discrimination of several methylation marker combinations in the training cohort for esophageal cancer detection in plasma samples.
| Methylation marker combination | AUC | p-value |
|---|---|---|
| ZNF582 + △Ct FAM19A4 | 0.661 | 0.002 |
| △Ct ZNF582 + △Ct FAM19A4 | 0.675 | 0.001 |
| ZNF582 + △Ct JAM3 | 0.648 | 0.004 |
| △Ct ZNF582 + △Ct JAM3 | 0.666 | 0.002 |
| ZNF582 + △Ct TERT | 0.666 | <0.001 |
| △Ct ZNF582 + △Ct TERT | 0.668 | <0.001 |
| ZNF582 + △Ct FAM19A4 + △Ct JAM3 | 0.641 | 0.007 |
| △Ct ZNF582 + △Ct FAM19A4 + △Ct JAM3 | 0.663 | 0.001 |
| ZNF582 + △Ct FAM19A4 + △Ct TERT | 0.655 | 0.001 |
| △Ct ZNF582 + △Ct FAM19A4 + △Ct TERT | 0.663 | 0.001 |
| ZNF582 + △Ct FAM19A4 + △Ct JAM3 + △Ct TERT | 0.656 | 0.001 |
| △Ct ZNF582 + △Ct FAM19A4 + △Ct JAM3 + △Ct TERT | 0.666 | 0.001 |